Clinical Trials Browser

Phase 1/2 × Non-Metastatic Prostate Cancer × Gefitinib × Clear all

NCT00239291 2009-04-23

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

Phase 1/2 Completed

Non-Metastatic Prostate Cancer